A global approach to antibiotic resistance

Picture Harpal Dhillon Chair RPS AMR groupBy Harpal Dhillon, Chair of the RPS Antimicrobial Expert Advisory Group

Bringing any new drug to market is a time consuming, costly and high-risk endeavour that typically takes 10 years, at an average development cost of about $1.3 billion U.S.

Even then, only one in five drugs tested in people is approved and reaches the market.  For antibiotics, the economic considerations are more challenging than for many other medical areas.  In addition to the unique scientific and regulatory challenges in antibiotic development, pricing and reimbursement do not reflect the true value of these life-saving drugs. Read more A global approach to antibiotic resistance

The pharmacy workforce: it’s more than just the numbers

david-banford(1)David Branford, English Pharmacy Board Chair

For most of my career there has been a shortage of pharmacists. Having a career that always provided a job has been a real luxury. It looks like that luxury is about to end. Read more The pharmacy workforce: it’s more than just the numbers

Fake medicines – a real danger

By Neal Patel, Head of Corporate Communications

As part of our commitment to patient safety, we’re proud to be involved in the Real Danger campaign, which aims to raise awareness of the dangers of buying prescription medicine online without a consultation with a heath professional or proper authority. We took part in important research that resulted in some alarming statistics:

Read more Fake medicines – a real danger